Role of Brain Biopsy in the Management of Focal Brain Lesions in HIV-Infected Patients
Neurol 54:993-997, Antinori,A.,et al, 2000
Diagnosis and Treatment of Intravascular Lymphomatosis
ArchNeurol 57:374-377, Baumann,T.P.,et al, 2000
MR Findings in Subacute Combined Degeneration of the Spinal Cord: A Case of Reversible Cervical Myelopathy
AJR 174:863-865, Ravina,B.,et al, 2000
Nitrous Oxide Anesthesia-Associated Myelopathy
ArchNeurol 57:380-382, Marie,R.,et al, 2000
Shaky-Leg Syndrome and Vitamin B12 Deficiency
NEJM 342:981, Benito-Leon,J.&Porta-Etessam,J., 2000
Blindness in a Strict Vegan
NEJM 342:897-898, Milea,D.,et al, 2000
Acromegaly Caused by Secretion of Growth Hormone by a Non-Hodgkin's Lymphoma
NEJM 342:1871-1876, Beuschlein,F.,et al, 2000
Helicobacter pylori -- Is It a Novel Causative Agent in Vitamin B12 Deficiency?
Arch Int Med 160:1349-1353,1229, Kaptan,K.,et al, 2000
Life-Threatening Tinnitus
Lancet 356:308, Javaheri,S. et al, 2000
Helicobacter pylori--Is it a Novel Causative Agent in Vitamin B12 Deficiency?
Arch Int Med 160:1349-1353, 1229, Kaptan,K. et al, 2000
Epstein-Barr Virus Infection
NEJM 343:481-492, Cohen,J.I., 2000
Acute Neurologic Decompensation in an Infant With Cobalamin Deficiency Exposed to Nitrous Oxide
J Pediatr 137:427-428, Felmet,K. et al, 2000
Multiple Sclerosis
NEJM 343:938-952, Noseworthy,J.H. et al, 2000
AIDS-Related Focal Brain Lesions in the Era of Highly Active Antiretroviral Therapy
Neurol 55:1194-1200, Ammassari,A.,et al, 2000
Primary Non-Hodgkin's Lymphoma of the Spinal Cord
Spine 26:2262-2264, Pels,H.,et al, 2000
Association of Primary Central Nervous System Lymphoma with Long-Term Azathioprine Therapy for Myasthenia Gravis?
Ann Neurol 47: 682-683, Herrlinger,U.,et al, 2000
Testicular Lymphoma is Associated With a High Incidence of Extranodal Recurrence
Cancer 88:154-161, Fonseca,R.,et al., 2000
Immune Cytopenias as the Presenting Finding in Primary Sjogrens Syndrome
QJM 93:825-829, Schattner,A.,et al, 2000
Guillain-Barre Syndrome in a Patient with Non-Hodgkins Lymphoma
Ann Oncol 11:217-220, Schwenk,D.Re.,et al, 2000
Neurological Manifestations of Chronic Hepatitis C
J Neurol 246:486-491, Heckmann, J.G.,et al, 1999
Spontaneous Remission of Primary Central Nervous System Lymphoma: Report of 3 Cases and Discussion of Pathophysiology
J Neuro-Oncology 42:151-159, Al-Yamany,M.,et al, 1999
Epstein-Barr Virus in Monitoring the Response to Therapy of Acquired Immunodeficiency-Related Primary Central Nervous System Lymphoma
Ann Neurol 5:259-261, Antinori,A.,et al, 1999
Value of Combined Approach with Thallium-201 Single-Proton Emission Computed Tomography and Epstein-Barr Virus DNA Polymerase Chain Reaction in CSF for the Diagnosis of AIDS-Related Primary CNS Lympho
J Clin Oncol 17:554-560, Antinori,A.,et al, 1999
Ibuprofen Treatment Versus Gradual Introduction of Interferon B-1b in patients with MS
Neurol 52:1893-1895, Rice,G.P.A.,et al, 1999
Lymphomatosis Cerebri Presenting as a Rapidly Progressive Dementia: Clinical, Neuroimaging and Pathologic Findings
Dement Geriatr Cogn Disord 10:152-157, Bakshi,R.,et al, 1999
Presenting Features and Value of Diagnostic Procedures in Leptomeningeal Metastases
Neurol 53:382-385, van Oostenbrugge,R.J.&Twijnstra,A., 1999
Intravenous Immunoglobulin Treatment in Neurologic Disorders
Arch Neurol 56:1025-1027,1032, Sorensen,P.S., 1999
Neurologic Complications Associated with Hepatitis C Virus Infection
Neurol 53:861-864, Tembl,J.I.,et al, 1999
Disease-Modifying Drugs for Relapsing-Remitting Multiple Sclerosis and Future Directions for Multiple Sclerosis Therapeutics
Arch Neurol 56:1079-1084, Rudick,R.A., 1999
Treatment Recommendations for Interferon-B in Multiple Sclerosis
JNNP 67:561-566, Polman,C.H.,et al, 1999
Multiple Sclerosis, Side Effects of Interferon Beta Therapy and Their Management
Neurol 53:1622-1627, Walther,E.U.&Hohlfeld,R., 1999
Population Based Cost Utility Study of Interferon Beta-1b in Secondary Progressive Multiple Sclerosis
BMJ 319:1529-1533, Forbes,R.B.,et al, 1999
Benign Acute Childhood Myositis, Laboratory and Clinical Features
Neurol 53:2127-2131, Mackay,M.T.,et al, 1999
Brain Biopsy in Patients with Acquired Immunodeficiency Syndrome, Diagnostic Value, Clinical Performance, and Survival Time
Arch Int Med 159:2590-2596, Hornef,M.W.,et al, 1999
Spastic Paraparesis after Anaesthesia
Lancet 353:554, Lee,P.,et al, 1999
Clinicopath Conf:Burkitt-Like B-Cell Lymphoma, Nocardiosis
NEJM 340:1188-1196, Case 11-1999, 1999
Clinicopath Conf:Lymphoplasmocytic Lymphoma with Motor Neuronopathy,Waldenstrom's Macroglobulinemia
NEJM 340:1661-1669, , 1999
Multiple Sclerosis,Therapeutic Update
Arch Neurol 56:277-280, Tselis,A.C.&Lisak,R.P., 1999
A 29-Year-Old Man with Multiple Sclerosis
JAMA 280:1432-1439, Rudick,R.A., 1998
MRI of Spinal Cord and Brain Lesions in Subacute Combined Degeneration
Neuroradiology 11:716-719, Katsaros,V.K.,et al, 1998
Oral or Parenteral Therapy for B12 Deficiency
Lancet 352:1721-1722, Elia,M., 1998
Amelioration of Flulike Symptoms at the Onset of Interferon B-1b Therapy in Multiple Sclerosis by Low-Dose Oral Steriods is Related to a Decrease in Interleukin-6 Induction
Ann Neurol 44:682-685, Martinez-Caceres,E.M.,et al, 1998
Neutralizing Antibodies to Interferon B-1a and Interferon B-1b in MS Patients are Cross-Reactive
Neurol 51:1698-1702, Khan,O.A. & Dhib-Jalbut,S., 1998
Myelopathy Caused by Nitrous Oxide Toxicity
AJNR 19:894-896, 9941998., Pema,P.J.,et al, 1998
Interferon B Therapy for Multiple Sclerosis
Lancet 352:1486-1487, Goodkin,D.E., 1998
Interferons in the Treatment of Multiple Sclerosis,Do They Prevent the Progression of the Disease?
Arch Neurol 55:1578-1580,1583, Rice,G.&Ebers,G, 1998
Interferons Should be Used to Treat Most Patients with MS
Arch Neurol 55:1581-1583, Herndon,R.M.&Jacobs,L, 1998
Placebo-Controlled Multicentre Randomised Trial of Interferon B-1b in Treatment of Secondary Progressive Multiple Sclerosis
Lancet 352:1491-1497,1486, European Study Group on Interferon B-1b in Seconda, 1998
Numb Chin Syndrome as the Initial Manifestation of HIV Infection
Neurol 50:511-512, Benito-Leon,J.,et al, 1998
Rate of Pregnancy-Related Relapse in Multiple Sclerosis
NEJM 339:285-291, 3391998., Confavreux,C.,et al, 1998